The many lives of thalidomide

Leuk Lymphoma. 2009 Jun;50(6):861-2. doi: 10.1080/10428190902964784.
No abstract available

Publication types

  • Comment

MeSH terms

  • Dose-Response Relationship, Drug
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
  • Leukemia, Lymphocytic, Chronic, B-Cell / pathology
  • Lymphocyte Count
  • Thalidomide / therapeutic use*
  • Treatment Outcome

Substances

  • Immunosuppressive Agents
  • Thalidomide